The impact of the first COVID-19 surge on severe asthma patients in the UK. Which is worse: the virus or the lockdown?
ERJ Open Res
; 7(1)2021 Jan.
Article
en En
| MEDLINE
| ID: mdl-33564672
Asthma therapy, including monoclonal antibodies, was not associated with #COVID19 infection or hospitalisation in a UK severe asthma population. Shielding led to a reported worsening of mental health in nearly half of patients contacted (47%). https://bit.ly/3jImUsG.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
ERJ Open Res
Año:
2021
Tipo del documento:
Article